Lung Cancer Life Expectancy

In general, life expectancy for asbestos lung cancer ranges from 7-16 months. Fortunately, lung cancer patients can receive treatments to improve their life expectancy and become survivors. Some patients have lived for 15 years or more with the right medical care.

Free Case Review

What Is the Life Expectancy of Lung Cancer?

Graphic noting that 35% of SCLC cancer patients and 80% of NSCLC patients achieve remission with treatmentsThe life expectancy of lung cancer is how long you are expected to live after a diagnosis.

Lung cancer has an overall life expectancy of less than two years, which is less favorable than many other cancer types. However, treatments may help you outlive the average lung cancer life expectancy and become a long-term survivor.

Lung cancer life expectancy depends on various factors, including your health, the type of lung cancer you have, and the cancer stage. Doctors will take all of these into account when coming up with a treatment plan to help you live longer.

Get a free case review now for help paying for asbestos lung cancer treatments that may improve your survival time.

Get Help for Asbestos Lung Cancer
  • Access Financial Aid and Justice
  • Learn About Your Options
  • Contact Us for Free
Free Case ReviewAn older man and his wife hold each other.

Lung Cancer Life Expectancy vs. Survival Rate

Many people confuse the terms “life expectancy” and “survival rate”. While both are important parts of an asbestos lung cancer prognosis, they aren’t the same.

  • Life expectancy is the amount of time doctors think you’ll live after a diagnosis.
  • Survival rates measure the percentage of people with the same stage and type of cancer who are still alive after a certain period of time (usually years).

The average 5-year survival rate for lung cancer is 18.6%, according to the American Lung Association (ALA). Treatment can help improve lung cancer survival rates and life expectancies.

Lung Cancer Life Expectancy by Type

Life expectancy varies with each of the three lung cancer types: non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and lung carcinoids. Find the life expectancies for every type below.

Life Expectancy for Non-Small Cell Lung Cancer

Non-small cell lung cancer is the most common type of lung cancer and is less aggressive than SCLC. The overall life expectancy for NSCLC is 11-13 months, according to a 2020 study.

NSCLC can also be classified into several subtypes, and each subtype has its own life expectancy.

Life expectancies for NSCLC subtypes include:

  • Adenocarcinoma: 25.82 months
  • Large cell carcinoma: 11-14.2 months
  • Squamous cell carcinoma: 10.1-12.9 months

Diagnosed with NSCLC? Call (877) 446-5767 to learn if you qualify for compensation to pay for life-extending treatments.

Small Cell Lung Cancer Life Expectancy

A male doctor meets with an older male patientsSmall cell lung cancer is much less common than NSCLC and is typically more aggressive. The life expectancy for SCLC is 7-16 months.

You can live longer with SCLC if you’re diagnosed before the cancer has spread.

Lung Carcinoid Life Expectancy

Lung carcinoid tumors are very rare but are much easier to treat compared to NSCLC or SCLC.

Patients with lung carcinoid tumors have an average life expectancy of 5.6 years, according to a 2021 report published in Lung Cancer.

Life Expectancy for Asbestos Lung Cancer

Patients with asbestos-related lung cancer have the same life expectancy as those with lung cancer not caused by asbestos.

Asbestos exposure can cause any of the other types of lung cancer listed above, with your life expectancy varying based on which type you have.

Lung Cancer Life Expectancy by Stage

Lung cancer stage greatly affects life expectancy. If you’re diagnosed in an earlier stage, metastasis (cancer spread) won’t have occurred, so the cancer will be easier to treat and you could live longer.

There are four stages of NSCLC and two stages of SCLC.

NSCLC life expectancy statistics by stage:

SCLC life expectancy statistics by stage:

  • Limited-stage SCLC: 12-16 months
  • Extensive-stage SCLC: 7-11 months

Doctors can recommend treatments that may help you live longer no matter which stage of lung cancer you have.

Get a free case review to learn if you qualify for compensation to help cover the costs of life-extending lung cancer treatments.

Get Help for Asbestos Lung Cancer
  • Access Financial Aid and Justice
  • Learn About Your Options
  • Contact Us for Free
Free Case ReviewAn older man and his wife hold each other.

What Affects Lung Cancer Life Expectancy?

Besides type and stage, other risk factors can affect your lung cancer life expectancy.

These factors include:

  • Early detection: Tests like lung cancer screenings can help diagnose you at an earlier stage, sometimes even before symptoms appear. An early lung cancer diagnosis typically gives you more treatment options to improve your life expectancy.
  • Patient age: Your life expectancy may be better if you’re a younger person. A study from Oncology Letters revealed that older lung cancer patients have significantly poorer health outcomes.
  • Patient health: If you’re in good overall health at the time of diagnosis, you’re more likely to tolerate major treatments that can help you live longer, like surgery. Lung cancer patients with pre-existing heart and lung problems generally have poor prognoses.
  • Patient sex: Women with lung cancer generally have slightly better outcomes than men.

Your doctor can explain how unique factors in your case may impact your asbestos lung cancer life expectancy.

How Treatments Improve Lung Cancer Life Expectancy

Arguably the best way to improve your life expectancy is to undergo lung cancer treatments. These treatments allow doctors to remove or shrink cancer tumors, which may give you more time to spend with your family.

Commonly used lung cancer treatments include:

  • Surgery removes the lung cancer tumor along with part or all of a lung. NSCLC patients who received surgery lived for 76.7 months on average, according to a 2023 review of Surveillance, Epidemiology, and End Results (SEER) data.
  • Chemotherapy uses drugs to kill cancer cells. Patients with late-stage NSCLC lived for over 9 months on average when chemotherapy was used alone, as noted in a 2023 study from The Lancet. In addition, chemotherapy may help patients live even longer when used with other treatments.
  • Immunotherapy boosts the immune system to fight cancer. Patients with metastatic NSCLC lived for 13.37 months on average when they received both immunotherapy and chemotherapy, according to a 2023 Biomedicines report.
  • Radiation therapy uses energy beams from protons and X-rays to kill cancer cells. Patients with advanced SCLC who received radiation and immunotherapy had a median survival of 11 months in a 2021 review of National Cancer Database statistics.
  • Targeted therapy blocks mutations found in cancer cells to kill them. According to a 2023 review of studies published in Cancer Cell International, this treatment can help patients live cancer-free for a few months to several years.

Doctors typically combine different treatments to remove as much of the cancer as possible, which may boost a patient’s life expectancy.

Contact us now to find out if you qualify for lung cancer compensation. Asbestos lung cancer treatment costs can add up, but we’re here to help you afford them.

What Is Lung Cancer Life Expectancy Without Treatment?

It’s important to get treated for asbestos lung cancer to improve your life expectancy.

Here are the average lung cancer life expectancies without treatment:

  • NSCLC: NSCLC patients who did not receive treatment only had an overall survival time of 7.15 months, according to a report published in Systematic Reviews.
  • SCLC: Untreated SCLC patients live for 2-4 months, as noted by a study from Breathe.

Getting treatment may give you more time to make memories with your loved ones. Even patients who were diagnosed with advanced cancer have lived for 15 years or more in some cases.

Lung Cancer Survivors

Lung cancer survivors have outlived average life expectancies, becoming beacons of hope for others diagnosed.

Long-term lung cancer survivors include:

  • Deborah, 24-year survivor: Deborah underwent lung cancer surgery less than a week after her adenocarcinoma diagnosis in 2000 and is still living a full life today.
  • David, 22-year survivor: A routine heart scan led to David’s diagnosis in the early 2000s. David survived thanks to several surgeries and has become an advocate for lung cancer research.
  • Jim, 19-year survivor: Jim was diagnosed with asbestos lung cancer and underwent aggressive treatments like surgery, chemotherapy, and radiation, which beat the cancer back.
  • Emily, 11-year survivor: Diagnosed with stage 4 NSCLC after never having smoked, Emily worked with top doctors to get treatments and has been cancer-free ever since.

Survivors like these should remind you that it’s possible to beat the odds and live a long time with lung cancer, even if you’ve been given an unfavorable life expectancy at first.

Get a free case review for help paying for the treatments needed to improve your life expectancy, so you can work toward becoming a lung cancer survivor.

Get Help for Asbestos Lung Cancer
  • Access Financial Aid and Justice
  • Learn About Your Options
  • Contact Us for Free
Free Case ReviewAn older man and his wife hold each other.

Get Help Improving Your Lung Cancer Life Expectancy

With the right treatments, your asbestos lung cancer life expectancy could change for the better, giving you more precious time with the ones you love.

It’s possible to live for 15 years or more — even with late-stage lung cancer.

Lung cancer treatments can be costly, but our team may be able to help you pursue financial compensation to cover expenses. This will allow you to focus on getting life-extending treatments without worrying about how to pay for them.

Call (877) 446-5767 or get a free case review to find out your eligibility for compensation to cover your treatment bills and any other expenses.

Lung Cancer Life Expectancy FAQs

How long can you live after being diagnosed with lung cancer?

Most lung cancer patients live 7-16 months after being diagnosed. However, It may be possible to live for 15 years or more with lung cancer depending on the specifics of your case.

You can improve your lung cancer life expectancy by getting treated soon after your diagnosis is confirmed.

Lung cancer can spread to other parts of the body very quickly without treatment, which can worsen your overall life expectancy.

Numerous studies have shown that lung cancer tumors can double in volume in just a few months to a few weeks.

By working with your lung cancer doctors, you may be able to get treatments that can help you live longer.

Worried about how you’ll pay for lung cancer treatment costs? We can help. Call (877) 446-5767 to learn more.

Lung cancer is not always terminal, even when it’s diagnosed in an advanced stage.

You have a better chance of surviving lung cancer if you’re diagnosed and treated before the cancer spreads. However, treatments have helped many patients whose cancer was considered terminal to become long-term survivors.

There isn’t a universal cure for lung cancer, but some patients are informally cured if doctors find no evidence of disease (NED) following treatments.

Early-stage lung cancer patients are more likely to achieve NED with aggressive treatments. It’s also possible to become cancer-free even if you’re in a later stage.

Get a free case review to see if we may be able to help you pay for treatments that could cure you or improve your survival time.

The average life expectancy of adenocarcinoma of the lung is 25.82 months, according to a January 2023 study published in Thoracic Cancer.

Adenocarcinoma lung life expectancies are better for patients whose tumors haven’t metastasized (spread).

The stage 4 or metastatic lung cancer life expectancy without treatment is only a few months.

In addition, 25% to 30% of patients with stage 4 NSCLC who do get treatment pass away within 3 months of diagnosis, according to a 2021 study from Frontiers in Oncology.

However, the remaining stage 4 patients lived for over 23 months on average in the study, showcasing the importance of getting treated.

Lung Cancer Group was established by a team of caring advocates so those with lung cancer and other asbestos-related diseases can get the help they deserve. Our site provides the most accurate and up-to-date information about lung cancer, its link to asbestos, and financial compensation available to patients. Contact us to learn more and get assistance.

  1. American Cancer Society (2023 January 12). Key Statistics for Lung Cancer. Retrieved May 16, 2024, from https://www.cancer.org/cancer/lung-cancer/about/key-statistics.html
  2. American Lung Association (2022 November 17). Lung Cancer Fact Sheet. Retrieved May 16, 2024, from https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/resource-library/lung-cancer-fact-sheet
  3. American Lung Association (2022 November 17). Physical Activity and Lung Cancer. Retrieved May 16, 2024, from https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/treatment/stay-healthy/physical-activity-and-lung-cancer
  4. American Lung Association (2022 November 17). Staying Healthy with Lung Cancer. Retrieved May 16, 2024, from https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/treatment/stay-healthy
  5. Araghi, M., et al. (2023, August 11). Recent advances in non-small cell lung cancer targeted therapy; an update review. Retrieved May 16, 2024, from https://link.springer.com/article/10.1186/s12935-023-02990-y
  6. Basumallik, N. & Agarwal, M. (2023, July 10). Small Cell Lung Cancer. Retrieved May 16, 2024, from https://www.ncbi.nlm.nih.gov/books/NBK482458/
  7. Benton, D (2015 January 22). Living Life AC (After Cancer). Retrieved May 16, 2024, from https://go2.org/blog/survivor-spotlight-living-life-ac-after-cancer/
  8. Breathe (2012). Update on small cell lung cancer management. Retrieved May 16, 2024, from https://breathe.ersjournals.com/content/8/4/314
  9. Canadian Cancer Society (2020 May). Prognosis and survival for lung cancer. Retrieved May 16, 2024, from https://cancer.ca/en/cancer-information/cancer-types/lung/prognosis-and-survival
  10. Canadian Cancer Society (2020 May). Survival statistics for small cell lung cancer. Retrieved May 16, 2024, from https://cancer.ca/en/cancer-information/cancer-types/lung/prognosis-and-survival/small-cell-lung-cancer-survival-statistics
  11. Cleveland Clinic (2022 September 28). Small Cell Lung Cancer. Retrieved May 16, 2024, from https://my.clevelandclinic.org/health/diseases/6202-small-cell-lung-cancer
  12. Clinical Trials Transformation Initiative. (n.d.). Jim Pantelas. Retrieved May 16, 2024, from https://ctti-clinicaltrials.org/our-work/patient-engagement/patient-engagement-collaborative/jim-pantelas/
  13. Cure (2021 February 23). New Study Seeks Origins of Young Lung Cancer. Retrieved May 16, 2024, from https://www.curetoday.com/view/new-study-seeks-origins-of-young-lung-cancer
  14. Gross, A.J., et al. (2021, November 1). Role of Thoracic Radiotherapy in Extensive Stage Small Cell Lung Cancer (ES-SCLC) in the Immunotherapy Era: A National Hospital-Based Registry Analysis. Retrieved May 16, 2024, from https://www.sciencedirect.com/science/article/abs/pii/S0360301621021738
  15. Guo, H. et. al (2021 December 21). “How Long Have I Got?” in Stage IV NSCLC Patients With at Least 3 Months Up to 10 Years Survival, Accuracy of Long-, Intermediate-, and Short-Term Survival Prediction Is Not Good Enough to Answer This Question. Retrieved May 16, 2024, from https://www.frontiersin.org/articles/10.3389/fonc.2021.761042/full
  16. Lee, P.M., et al. (2023, July 6). First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study. Retrieved May 16, 2024, from https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00774-2/abstract#%20
  17. Lung Cancer Foundation of America (n.d.). David Sturges. Retrieved May 16, 2024, from https://lcfamerica.org/survivor/david-sturges/
  18. Mayo Clinic (2022 March 22). Lung cancer. Retrieved May 16, 2024, from https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627
  19. Moninger, J (2019 November 18). Longtime Lung Cancer Thrivers. Retrieved May 16, 2024, from https://www.curetoday.com/view/longtime-lung-cancer-thrivers
  20. National Cancer Institute (2023 February 17). Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version. Retrieved May 16, 2024, from https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq
  21. National Institute on Aging (2020 April 9). What Are Clinical Trials and Studies? Retrieved May 16, 2024, from https://www.nia.nih.gov/health/what-are-clinical-trials-and-studies
  22. National Library of Medicine: PubMed Central (2013 February). Systematic Reviews. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis. Retrieved May 16, 2024, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579762/
  23. National Library of Medicine: PubMed Central (2013 November). Oncology Letters. Age is a prognostic factor affecting survival in lung cancer patients. Retrieved May 16, 2024, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813578/
  24. Onal, O. et. al (2020 December 17). Turkish Journal of Medical Sciences. Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancer. Retrieved May 16, 2024, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775717/
  25. Shalata, W., et al. (2023, August 31). Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer. Retrieved May 16, 2024, from https://www.mdpi.com/2227-9059/11/9/2438
  26. Soldath, P., et al. (2021, April 26). Long-term survival and recurrence after resection of bronchopulmonary carcinoids: A single-center cohort study of 236 patients. Retrieved May 16, 2024, from https://www.lungcancerjournal.info/article/S0169-5002(21)00150-1/fulltext
  27. West, H., et al. (May 2023). Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare Data. Retrieved May 16, 2024, from https://www.sciencedirect.com/science/article/pii/S152573042200290X
  28. Zhao, Z., et al. (2023, January 24). Specific organ metastases and prognosis in lung adenocarcinoma. Retrieved May 16, 2024, from https://onlinelibrary.wiley.com/doi/full/10.1111/1759-7714.14801
Free Case Review

Get Financial Compensation for Lung Cancer

  • Afford medical expenses and any other bills
  • Find peace of mind for you and your family
  • Get justice from the companies that harmed you

Call (877) 446-5767 or fill out the form to connect with our team and pursue financial compensation after a lung cancer diagnosis.

Start a Free Case Review

Secure Submission

Call us at (877) 446-5767 Talk to us via Live Chat